Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis
Phenotype |liver disease
Sentences 177
PubMedID- 22308138 Of late, liver diseases due to chronic hepatitis b and c infection are becoming a leading cause of death and decrease life expectancy among persons with hiv infections worldwide [1].
PubMedID- 20531062 Objective: liver disease associated with hepatitis c virus (hcv) is a serious cause of mortality among people living with human immunodeficiency virus/acquired immunodeficiency syndrome (hiv/aids) (plwha).
PubMedID- 23703797 Vitamin d is an important immune modulator that plays an emerging role in inflammatory and metabolic liver diseases, including infection with hepatitis c virus (hcv).
PubMedID- 21194431 The underlying etiology of liver disease was attributed to hepatitis b virus (hbv) infection if patients were seropositive for hepatitis b surface antigen (hbsag, ria kits, abbott laboratories, north chicago, il, usa) and attributed to hepatitis c virus (hcv) infection if patients were seropositive for an antibody against hcv by a second-generation enzyme immunoassay (abbott laboratories, il).
PubMedID- 22419479 We enrolled 184 hepatitis c-infected patients with chronic liver diseases or hcc, 57 healthy subjects and 27 hcc patients with other etiology.
PubMedID- 23796722 Methods: two patients, who had already received a liver transplant (lt) in the past, with an end-stage liver disease due to recurrent hepatitis c virus cirrhosis, suffering acute-on-chronic liver failure while on the waiting list for an lt, received ht as a bridge to whole-organ retransplantation.
PubMedID- 24377696 Severe forms of alcoholic hepatitis in patients with alcoholic liver disease are associated with high mortality; it is therefore vital to identify those patients at greatest risk of mortality in 28 days as they may benefit from aggressive intervention.
PubMedID- 22359532 Nested case control studies have a distinct advantage from traditional case control studies because both cases and controls are chosen from the same, well-defined source population, in this study from the halt-c study population where all patients had chronic hepatitis c infection with chronic liver disease.
PubMedID- 23707779 Dietary cholesterol intake is associated with progression of liver disease in patients with chronic hepatitis c: analysis of the hepatitis c antiviral long-term treatment against cirrhosis trial.
PubMedID- 26357642 Selected mirna biomarkers from patients with hbv infection, patients with skeletal muscle disease, and healthy subjects.113 they showed that increased serum mir-122 levels correlated with histopathologic alterations and appeared earlier compared with alanine aminotransferase (alt) levels, which remained within the reference intervals.113 also, increased serum mirna-122 levels were more specific for liver injury than for other organ damage.113 other studies showed that serum mir-122 may allow for discrimination of hcc patients from healthy subjects but was not useful for distinguishing hcc cases from hbv carriers.114,115 serum mir-223 together with mir-125b-5p have been reported as promising biomarkers of very early hbv-positive hcc, even in advanced stages of liver disease due to chronic hepatitis b.116 other mirnas have been suggested to have great diagnostic value.
PubMedID- 23547940 Deaths attributable to viral hepatitis primarily result from chronic liver disease and liver failure, and viral hepatitis may not consistently be listed as the underlying cause of death, leading to underestimation of deaths due to chronic viral hepatitis.
PubMedID- 24130726 This study analyses the evolution of liver disease in women with chronic hepatitis c during the third trimester of pregnancy and the post-partum period, as a natural model of immune modulation and reconstitution.
PubMedID- 26502286 In contrast, zinc has antioxidant properties, and its level in chronic liver disease due to hepatitis c is inversely correlated with viral load [66].
PubMedID- 24622763 Most patients had underlying liver disease due to hepatitis b or c virus infection or preoperative chemotherapy: 26 patients (33.8 %) had chronic hepatitis, 20 (26.3 %) had liver cirrhosis, and 23 (30.3 %) had received preoperative chemotherapy.
PubMedID- 23874824 Among the main causes of liver disease, co-infection with the hepatitis c (hcv) or hepatitis b (hbv) virus is the most frequent and has the worst prognosis [3].
PubMedID- 22505377 Background/aims: hepatitis c virus leads to chronic liver disease, cirrhosis and hepatocellular cancer.
PubMedID- 25400432 Chronic liver disease including hepatitis c virus (hcv) infection is one of the main cause for the development of hepatic angiogenesis and thereby plays a critical role in the modulation of hepatic angiogenesis that finally leads to hepatocellular carcinoma progression and invasion.
PubMedID- 20616580 Lipid metabolism and liver disease in hepatitis c viral infection.
PubMedID- 22980664 [expression of mcp-1 in the patients of chronic hepatitis b complicated with nonalcoholic fatty liver disease].
PubMedID- 24658127 However, our findings and those from spain [31] conflict with a recent finding from turkey of the existence of a correlation between serum hbsag levels and hdv viremia, regardless of histological staging and the grading of liver disease in patients with chronic hepatitis delta [11].
PubMedID- 21415769 Background: hepatitis b leads to chronic liver disease, cirrhosis, and hepatocellular cancer.
PubMedID- 25995680 In korea, one study reports that the underlying liver diseases of hcc patients included hepatitis b (72.3%), hepatitis c (11.6%), alcoholic liver disease in (10.4%), and non-b non-c hepatitis (0.7%) (12).
PubMedID- 21789263 The incidence of hepatocellular carcinoma (hcc) has risen as a result of increased global burden of chronic liver disease due to hepatitis b and c virus infections, aflatoxin b1, alcoholism, and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis associated with the metabolic syndrome.
PubMedID- 23469281 Still, certain co-infections and -morbidities such as liver disease due to viral hepatitis b and c infection cause considerable morbidity and mortality: data from the d:a:d cohort demonstrated liver-related complications to be the leading cause of non-aids related deaths of patients under cart in europe, the usa and australia in 2006 [3].
PubMedID- 23622604 There is an extremely high burden of liver disease owing to viral hepatitis b (hbv); about 2 billion people are infected and 350 million are chronic carriers of hbv worldwide.
PubMedID- 21209701 End-stage liver disease due to hepatitis c (hcv) and cirrhosis from alcohol (ald) are the commonest indications for liver transplantation in the western countries.
PubMedID- 25208465 liver diseases were mostly attributed to hepatitis b virus infection (32%).

Page: 1 2 3 4